Table 1 Patients’ baseline characteristics
All patients n = 291 | SAE n = 127 | non-SAE n = 164 | P | |
|---|---|---|---|---|
Age (years), median | 59 [45, 72] | 64 [48, 76] | 55 [43, 68] | < 0.01* |
Sex (%) | ||||
Male | 213 (73.2) | 90 (70.9) | 123 (75.0) | 0.430 |
Female | 78 (26.8) | 37 (29.1) | 41 (25.0) | |
Underlying diseases (%) | ||||
Hypertension | 75 (25.8) | 41 (32.3) | 34 (20.7) | 0.025* |
Diabetes | 40 (13.7) | 23 (18.1) | 17 (10.4) | 0.057 |
COPD | 28 (9.6) | 10 (7.9) | 18 (11.0) | 0.374 |
CHF | 37 (12.7) | 19 (15.0) | 18 (11.0) | 0.312 |
CHD | 12 (4.1) | 4 (3.1) | 8 (4.9) | 0.462 |
CKD | 17 (5.8) | 7 (5.5) | 10 (6.1) | 0.833 |
Malignant tumor | 44 (15.1) | 22 (17.3) | 22 (13.4) | 0.356 |
Immune diseases | 4 (1.4) | 1 (0.8) | 3 (1.8) | 0.803 |
Others | 26 (8.9) | 13 (10.2) | 13 (7.9) | 0.493 |
Disease severity (median) | ||||
SOFA score | 5 [2, 7] | 7 [5, 10] | 3 [1, 5] | < 0.01* |
APACHE II score | 11 [8, 15] | 15 [12, 19.5] | 9 [6, 11] | < 0.01* |
Outcome | ||||
Hospital LOS (median) | 20 [11, 30] | 19 [9, 28] | 21 [13, 36] | 0.143 |
28-day mortality (%) | 77 (26.5) | 54 (42.5) | 21 (12.8) | < 0.01** |